ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To assess signalling pathways affected by BCR-ABL, we monitored the phosphorylation of pCrkL by immunoblotting following 4 h of treatment ±BMP4 stimulation in normal and CML-iPSCs (Fig. 6f–i).